Interestingly, IFN-β inhibits the infiltration of proangiogenic neutrophils that express VEGF, MMP-9, and CXCR4 and reduces tumor growth, suggesting a potential therapeutic approach for targeting neutrophil-mediated tumor angiogenesis [188]. This evidence concerns the gene MMP9 and neoplasm.